Aug 29, 2019
CRISPR Nanogel Pill Could Be the Answer to Stop Triple-Negative Breast Cancer
Posted by Genevieve Klien in categories: biotech/medical, genetics
The answer to halting triple-negative breast cancer, the deadliest of all breast cancers, may have just been discovered by researchers from Boston Children’s Hospital.
A CRISPR gene-editing system — all encompassed into a nanogel capsule, that is then injected into the affected person’s body — is the potential antidote to stopping the growth of triple-negative breast cancer tumors.
Continue reading “CRISPR Nanogel Pill Could Be the Answer to Stop Triple-Negative Breast Cancer” »